MicroRNA-Gene Association As a Prognostic Biomarker in Cancer Exposes Disease Mechanisms

PLoS Computational Biology

Volumn 9, Issue 11, 2013, Pages

  Ben Hamo, Rotem ^a   Efroni, Sol ^a  

^a BAR ILAN UNIVERSITY   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

DIAGNOSIS; DISEASE CONTROL; DISEASES; GENE EXPRESSION REGULATION; GENE THERAPY; GENOME; RNA; TUMORS;

CANCER DEVELOPMENT; GENE ASSOCIATIONS; GENE MODIFICATION; GENES EXPRESSION; GLIOBLASTOMA MULTIFORM; HUMAN CANCER; RNA MOLECULES; SURVIVAL RATE; TRANSCRIPTIONAL NETWORKS; TUMOR PROGRESSIONS;

GENE EXPRESSION;

MICRORNA; MICRORNA 126; MICRORNA 128A; MICRORNA 202; MICRORNA 301; MICRORNA 330 3P; MICRORNA 365; MICRORNA 373; MICRORNA 489; MICRORNA 500; MICRORNA 556; MICRORNA 660; MICRORNA 7; MICRORNA 768 5P; MICRORNA 769 5P; SMALL UNTRANSLATED RNA; UNCLASSIFIED DRUG;

ALGORITHM; ARTICLE; BINDING SITE; CANCER GROWTH; CANCER PROGNOSIS; CARCINOGENESIS; DEREGULATION; DNA MODIFICATION; GENE EXPRESSION REGULATION; GENE FUNCTION; GENE SEQUENCE; GENETIC ASSOCIATION; GENETIC VARIABILITY; GLIOBLASTOMA; HUMAN; MACHINE LEARNING; NUCLEOTIDE SEQUENCE; PHENOTYPE; SENSITIVITY ANALYSIS; VALIDATION STUDY;

ALGORITHMS; DATABASES, GENETIC; GENOMICS; HUMANS; KAPLAN-MEIER ESTIMATE; MICRORNAS; NEOPLASMS; PROGNOSIS; REPRODUCIBILITY OF RESULTS; TUMOR MARKERS, BIOLOGICAL;

EID: 84888210254     PISSN: 1553734X     EISSN: 15537358     Source Type: Journal    
DOI: 10.1371/journal.pcbi.1003351     Document Type: Article

References (30)

1. Alberts B (2008) Molecular biology of the cell. New York: Garland Science.
2. Negrini M, Ferracin M, Sabbioni S, Croce CM, (2007) MicroRNAs in human cancer: from research to therapy. J Cell Sci 120: 1833-1840.
3. Scott GK, Goga A, Bhaumik D, Berger CE, Sullivan CS, et al. (2007) Coordinate suppression of ERBB2 and ERBB3 by enforced expression of micro-RNA miR-125a or miR-125b. J Biol Chem 282: 1479-1486.
4. Cimmino A, Calin GA, Fabbri M, Iorio MV, Ferracin M, et al. (2005) miR-15 and miR-16 induce apoptosis by targeting BCL2. Proc Natl Acad Sci U S A 102: 13944-13949.
5. Takamizawa J, Konishi H, Yanagisawa K, Tomida S, Osada H, et al. (2004) Reduced expression of the let-7 microRNAs in human lung cancers in association with shortened postoperative survival. Cancer Res 64: 3753-3756.
6. Si ML, Zhu S, Wu H, Lu Z, Wu F, et al. (2007) miR-21-mediated tumor growth. Oncogene 26: 2799-2803.
7. Li M, Li J, Ding X, He M, Cheng SY, (2010) microRNA and cancer. AAPS J 12: 309-317.
8. Jackson RJ, Standart N, (2007) How do microRNAs regulate gene expression? Sci STKE 2007: re1.
9. Vasudevan S, Tong Y, Steitz JA, (2007) Switching from repression to activation: microRNAs can up-regulate translation. Science 318: 1931-1934.
10. Krex D, Klink B, Hartmann C, von Deimling A, Pietsch T, et al. (2007) Long-term survival with glioblastoma multiforme. Brain 130: 2596-2606.
11. Prados M, Cloughesy T, Samant M, Fang L, Wen PY, et al. (2011) Response as a predictor of survival in patients with recurrent glioblastoma treated with bevacizumab. Neuro Oncol 13: 143-151.
12. McLendon R, Friedman A, Bigner D, Van Meir EG, Brat DL, et al. (2008) Comprehensive genomic characterization defines human glioblastoma genes and core pathways. Nature 455: 1061-1068.
13. Xiao F, Zuo Z, Cai G, Kang S, Gao X, et al. (2009) miRecords: an integrated resource for microRNA-target interactions. Nucleic Acids Res 37: D105-110.
14. Bland JM, Altman DG, (1998) Survival probabilities (the Kaplan-Meier method). BMJ 317: 1572.
15. Enerly E, Steinfeld I, Kleivi K, Leivonen SK, Aure MR, et al. (2011) miRNA-mRNA integrated analysis reveals roles for miRNAs in primary breast tumors. PLoS One 6: e16915.
16. Buffa FM, Camps C, Winchester L, Snell CE, Gee HE, et al. (2011) microRNA-associated progression pathways and potential therapeutic targets identified by integrated mRNA and microRNA expression profiling in breast cancer. Cancer Res 71: 5635-5645.
17. Eid MA, Kumar MV, Iczkowski KA, Bostwick DG, Tindall DJ, (1998) Expression of early growth response genes in human prostate cancer. Cancer Res 58: 2461-2468.
18. Jamieson GA Jr, Mayforth RD, Villereal ML, Sukhatme VP, (1989) Multiple intracellular pathways induce expression of a zinc-finger encoding gene (EGR1): relationship to activation of the Na/H exchanger. J Cell Physiol 139: 262-268.
19. Molnar G, Crozat A, Pardee AB, (1994) The immediate-early gene Egr-1 regulates the activity of the thymidine kinase promoter at the G0-to-G1 transition of the cell cycle. Mol Cell Biol 14: 5242-5248.
20. Mitchell A, Dass CR, Sun LQ, Khachigian LM, (2004) Inhibition of human breast carcinoma proliferation, migration, chemoinvasion and solid tumour growth by DNAzymes targeting the zinc finger transcription factor EGR-1. Nucleic Acids Res 32: 3065-3069.
21. Gonzaga-Jauregui C, Lupski JR, Gibbs RA, (2012) Human genome sequencing in health and disease. Annu Rev Med 63: 35-61.
22. Bolstad BM, Irizarry RA, Astrand M, Speed TP, (2003) A comparison of normalization methods for high density oligonucleotide array data based on variance and bias. Bioinformatics 19: 185-193.
23. SPSS Inc. (2000) SPSS for Windows, release 13.0.0. Chicago: SPSS Inc.
24. Lewis BP, Shih IH, Jones-Rhoades MW, Bartel DP, Burge CB, (2003) Prediction of mammalian microRNA targets. Cell 115: 787-798.
25. Lewis BP, Burge CB, Bartel DP, (2005) Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell 120: 15-20.
26. Krek A, Grun D, Poy MN, Wolf R, Rosenberg L, et al. (2005) Combinatorial microRNA target predictions. Nat Genet 37: 495-500.
27. John B, Enright AJ, Aravin A, Tuschl T, Sander C, et al. (2004) Human MicroRNA targets. PLoS Biol 2: e363.
28. Kiriakidou M, Nelson PT, Kouranov A, Fitziev P, Bouyioukos C, et al. (2004) A combined computational-experimental approach predicts human microRNA targets. Genes Dev 18: 1165-1178.
29. Rusinov V, Baev V, Minkov IN, Tabler M, (2005) MicroInspector: a web tool for detection of miRNA binding sites in an RNA sequence. Nucleic Acids Res 33: W696-700.
30. Benjamini Y, Hochberg Y, (1995) Controlling the False Discovery Rate- a Practical and Powerful Approach to Multiple Testing. Journal of the Royal Statistical Society Series B-Methodological 57: 289-300.